Aug 28, 2024 · Pfizer-BioNTech COVID-19 Vaccine is indicated for individuals 5 through 11 years of age (via a 10mcg / 0.3mL single-dose vial presentation) and for individuals 6 months through 4 years of age (via a 3mcg / 0.3mL multi-dose vial (3 doses per vial) presentation).

Oct 15, 2024 · The Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula) is authorized for all doses administered to individuals 6 months through 11 years of age to prevent COVID-19.

The Pfizer–BioNTech COVID-19 vaccine is used to provide protection against COVID-19, caused by infection with the SARS-CoV-2 virus, by eliciting an immune response to the S antigen. [1] [2] [31] [40] The vaccine is used to reduce morbidity and mortality from COVID-19. [35]

Aug 16, 2024 · Although the licensed vaccine (Comirnaty ®) is FDA-approved in patients aged 16 or older for 2 doses , Pfizer-BioNTech COVID-19 vaccine is an unapproved product authorized for emergency use in individuals aged 12 through 15 years and to provide a third dose to individuals aged 12 years or older who are solid organ transplant recipients or have a...

Guidance below summarizes basic storage, preparation, scheduling, administration, and dosage for all 2024–25 Pfizer-BioNTech COVID-19 vaccine products. Between: -90°C and -60°C (-130°F and -76°F) until the expiration date. 2°C and 8°C (36°F and 46°F) for up to 10 weeks. 8°C and 25°C (46°F and 77°F) for up to 12 hours prior to the first puncture.

Jan 7, 2025 · Getting a COVID-19 vaccine is a safer, more reliable way to build protection than getting sick with COVID-19. When are you up to date? Your child is up to date when they have received all recommended doses, including at least 1 dose of the 2024–2025 COVID-19 vaccine. 1 dose of the 2024–2025 Pfizer-BioNTech COVID-19 vaccine.

Emergency uses of COVID-19 vaccines from BioNTech and Pfizer, including Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula), have not been approved or licensed by FDA, but have been authorized by FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) in individuals 6 months of age and older.

Sep 16, 2024 · Pfizer-BioNTech COVID-19 vaccine 2024-2025 formula is authorized for people ages 6 months through 11 years. Comirnaty is approved for people age 12 and older. The vaccines that help protect against COVID-19 are safe and effective based on clinical trials and continued monitoring.

Feb 27, 2024 · There is evidence that the Pfizer/BioNTech and Moderna mRNA vaccines may rarely cause inflammation of the heart muscle (myocarditis) or of the surrounding lining (pericarditis),...

Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as...